Warren Buffett Eliminated This Stock From Berkshire’s Portfolio Last Year

Last year, Warren Buffett and his team at Berkshire Hathaway eliminated its stake in Globe Life (NYSE: GL), a stock that had been a part of its portfolio for over two decades. The company faced some serious legal issues last year and suffered a deep sell-off earlier this year when it was the subject of a short-seller report.

Since the start of the year, Globe Life stock has plummeted 32.4%, according to data from S&P Global Market Intelligence. Here’s what investors should know about the dip and what’s next for Globe Life.

Globe Life faces serious accusations

Last year, storm clouds began to emerge over Globe Life when one of its subsidiaries, American Income Life Insurance Co. and Arias Agencies, faced a lawsuit accusing it of inappropriate workplace conduct, including rampant drug use, sexual abuse, and degradation of agents who didn’t hit sales targets. Compounding its troubles were accusations from a former executive who said he was fired for blowing the whistle on “potentially illegal” sales practices.

Warren Buffett, who emphasizes management’s character and integrity, seemingly took the accusations quite seriously, and Berkshire sold its stake in the insurer last year. Although it wasn’t a sizable position, it has long been a staple of Berkshire Hathaway’s portfolio since 2001.

Investors seemed to shrug off the accusations as the calendar turned to 2024. Then, on March 6, the U.S. Department of Justice issued subpoenas to Globe Life and American Income Life as part of an investigation into allegations of fraud and misconduct at one of its top life insurance agencies.

In early April, Globe Life took another hit when short seller Fuzzy Panda Research accused the insurer of “extensive” insurance fraud that was ignored by management. The short seller interviewed former employees “who showed us where the fraud was hidden” and that the fraud was ignored by management despite being “obvious and reported hundreds of times.”

What’s next for Globe Life?

Globe Life has since recovered from its low of $39 per share since the short report was published, indicating that perhaps the sell-off was overdone. Today, the company is priced at a dirt cheap valuation of 8.2 times earnings.

GL PE Ratio Chart

However, the company continues to face questions and received “a preliminary, informal inquiry from the SEC” in May to investigate the short sellers’ claims. While it is not a formal investigation by the SEC, these issues pose a risk and will be an overhang for Globe Life’s stock for the time being.

Story continues

Should you invest $1,000 in Globe Life right now?

Before you buy stock in Globe Life, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Globe Life wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $791,929!*

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.

See the 10 stocks »

*Stock Advisor returns as of July 8, 2024

Courtney Carlsen has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Berkshire Hathaway. The Motley Fool has a disclosure policy.

Warren Buffett Eliminated This Stock From Berkshire’s Portfolio Last Year. It Has Fallen 32% in the First Half of 2024. was originally published by The Motley Fool

Read The Full Article Here